DOH eyes clinical trial on four possible COVID-19 cures

Published April 27, 2020, 12:00 AM

by manilabulletin_admin

By Noreen Jazul

The Department of Health is eyeing to start the clinical trials on four possible coronavirus disease (COVID-19) cures by Friday.

Health Assistant Secretary Maria Rosario Vergeire (PNA)
Health Assistant Secretary Maria Rosario Vergeire (PNA)

“Nung nag usap usap kami kasama ng proponent, ang sinasabi nila makakapag umpisa sila ng Biyernes, makakuha lang sila ng gamot,” Health Undersecretary Maria Rosario Vergeire told DZMM radio on Monday. (When we discussed this together with the proponent and the participating hospitals, they said they can start the clinical trial by Friday if they get the drugs needed for the trial.)

Vergeire said the World Health Organization (WHO), which spearheaded the Solidarity Trial, is still processing the shipment of the four off-label drugs to be used in the clinical trial.

Vergeire said the drugs might arrive in the country around “early part of next next week,” as announced by WHO.

The health official, however, said other hospitals can proceed with the trial since the DOH has a stock of the other drugs which will be up for testing.

“Yung mga ospital, gagawan na natin ng imbentaryo, kung meron sila nung initial na mga gamot, maari na nating umpisahan,” she said. (We will make an inventory for the participating hospitals, if they have an initial stock of the drugs, then we can start with the trial.)

The four drugs which will be used for the clinical trial are the antiviral Remdesivir, antimalarial drug Chloroquine or Hydroxychloroquine, antiretroviral drugs used to treat HIV Lopinavir with Ritonavir, and Lopinavir with Ritonavirplus Interferon beta-1a. (With a report from Analou De Vera)